Special Issue "Brain Metabolomics: New Perspective on Neurodegenerative Disorders"
Deadline for manuscript submissions: 30 June 2022.
This Special Issues broadly discusses protein clearance mechanisms via autophagy, the proteasome, and the lysosome in neurodegenerative diseases. It also will consider the direct effects on angiogenesis and the blood–brain barrier in health, disease and response to treatments. Inflammatory processes that are concurrent or independent of neurotoxic protein accumulation will also be considered. Papers concerning drug development as a strategy to treat neurodegeneration via manipulation of autophagy, the lysosome, and inflammation and restoration of the blood–brain barrier are particularly welcome.
Dr. Charbel Moussa
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Metabolites is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- new drug
- drug developments